CRP and neoplasm: In this study, we specifically investigated the prognostic predictors in a cohort of HCC patients at one month after treatment with SIRT and established a prognostic scoring model based on the following factors: the tumor response, the number of tumor lesions, MELD score and serum CRP levels.